Purchase Order 36C24422P0612
Award Date 6/30/22
Potential Completion Date 6/30/24
Potential Value $1.9M
Federal Agency
Awardee
Ultimate Awardee
NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Sterling, VA, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- Sofie CO., doing business as IBA Molecular, was awarded a $5.96 million firm fixed-price purchase order by Veterans Integrated Service Network 19 (VA VISN 19) on October 1, 2023, for the supply of positron emission tomography/computed tomography (PET/CT) radiopharmaceuticals through September 30, 2028. The contract was executed without set-aside designation and covers routine delivery of specialized imaging agents to support VA medical facilities, including F-18 fluorodeoxyglucose (FDG), F-18...
- The U.S. Department of Veterans Affairs, through Veterans Integrated Service Network 4, awarded a $1.39 million firm fixed-price purchase order to Sofie CO. (doing business as IBA Molecular) on May 1, 2024, for the supply of FDG (fluorodeoxyglucose) and NEURACEQ (florbetaben F-18) radiopharmaceuticals. These PET (positron emission tomography) imaging agents are critical diagnostic tools used for oncology imaging and Alzheimer's disease detection, respectively, supporting the VA's medical imaging...
- Sofie CO., doing business as IBA Molecular, was awarded a $830,796.45 firm fixed-price delivery order on March 15, 2026, for the supply of Positron Emission Tomography (PET) radiopharmaceuticals to support the Veterans Integrated Service Network 2 (VISN 2). The contract, which carries no set-aside designation, has an ultimate completion date of March 14, 2027, with performance occurring in Sterling, Virginia. The award represents a delivery order under an existing indefinite delivery vehicle,...
- This is a firm fixed-price purchase order awarded by the Veterans Integrated Service Network 16 (VISN 16) of the U.S. Department of Veterans Affairs (VA) to Sofie CO., doing business as Sofie. The contract, valued at $690,810.00, is for the supply of FDG-F18 radiopharmaceuticals. Sofie is a subsidiary of Sofie Biosciences, Inc. that specializes in the development and delivery of molecular diagnostics and therapeutics, including radiopharmaceuticals for medical imaging and cancer treatment. The...
- The Department of Veterans Affairs, through Veterans Integrated Service Network (VISN) 8, awarded a firm fixed-price purchase order to Sofie CO. (doing business as IBA Molecular) for the supply of Amyloid Florbetaben F-18 Injections, an FDA-approved radiopharmaceutical used for positron emission tomography (PET) imaging in Alzheimer's disease detection. The contract, valued at $684,219.20 with a ceiling through September 30, 2029, represents a modification to reflect updated pricing on the...
- This is a federal contract award to Sofie CO., doing business as IBA Molecular, a for-profit subsidiary of Sofie Biosciences, Inc. The contract, awarded by the Department of Veterans Affairs (VA) Veterans Integrated Service Network 10, is for the delivery of radiopharmaceuticals and positron emission tomography (PET) imaging agents. The contract has a ceiling value of $1,981,334.52 and a period of performance that runs through September 30, 2026. This award is not set aside and is a delivery...
- This delivery order, awarded September 1, 2024, represents Option Year 2 of an existing contract vehicle with Sofie CO. (doing business as IBA Molecular), a Sterling, Virginia-based supplier of molecular diagnostics and therapeutic radiopharmaceuticals. The $194,870.88 firm fixed-price delivery order is funded by the Department of Veterans Affairs through Veterans Integrated Service Network 15 and is scheduled for completion by August 31, 2027. This award carries no set-aside designation and...
- Sofie CO., doing business as IBA Molecular, was awarded a delivery order valued at $1,176,442.72 on September 1, 2025, by the Department of Veterans Affairs through Veterans Integrated Service Network 17 (VISN 17) for the supply of PYLARIFY (piflufolastat F-18), a positron emission tomography imaging agent used in prostate cancer detection. This firm fixed-price delivery order, with an ultimate completion date of August 31, 2026, carries no set-aside designation and will be performed in...
- This is a firm fixed-price purchase order awarded by the Veterans Integrated Service Network 4 (VISN 4) of the Department of Veterans Affairs (VA) to Sofie CO., a subsidiary of Sofie Biosciences, Inc. The contract, valued at $663,619.64, is for the supply of radiopharmaceuticals to support medical imaging and cancer treatment programs for veterans. Sofie is an experienced provider of specialized imaging agents, prostate cancer detection tools, and injectable cancer drugs to the VA, the Defense...
- This is a federal contract award from the Department of Veterans Affairs (VA) to Sofie CO., a subsidiary of Sofie Biosciences, Inc. The $204,375.00 firm-fixed-price purchase order is for the supply of radiopharmaceutical products. The contract does not have a set-aside designation. Sofie CO. is a specialized provider of molecular diagnostics and therapeutics, including radiopharmaceuticals, pharmaceuticals, and related services to various federal agencies such as the VA, Defense Health Agency...